ABSTRACT

MMWR Early Release: Morbidity and Mortality Weekly Report, March 1, 2022: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years -- VISION Network, 10 States, April 2021-January 2022   [open pdf - 275KB]

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). [It] is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. This Early Release issue of MMWR contains the following article: "Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years -- VISION Network, 10 States, April 2021-January 2022." Notifiable Diseases and Mortality Tables from MMWR can be accessed at the following link [http://www.cdc.gov/mmwr/index2022.html].

Publisher:
Date:
2022-03-01
Series:
Copyright:
Public Domain
Retrieved From:
Morbidity and Mortality Weekly Report: http://www.cdc.gov/mmwr/index.html/
Format:
pdf
Media Type:
application/pdf
Source:
MMWR Early Release: Morbidity and Mortality Weekly Report (March 1, 2022), v.71
URL:
Help with citations